ArticleUrology2025
Self-Efficacy in Managing Female Sexual Dysfunction in Interstitial Cystitis.
Article in Urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo examine relations between clinical features and female sexual dysfunction (FSD) in a sample of women with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS), with a focus on sexual self-efficacy, or confidence in ability to manage symptoms. FSD is prevalent in IC/BPS. Several areas of sexual functioning are impacted, including experiences of pain during and after sex which is significantly disruptive to quality of life. Despite evidence that emotional health and FSD relate, less is known about how to address FSD in IC/BPS.
methodsSixty-eight female participants [m = 43.89 (SD = 13.15) years] with IC/BPS reported demographics, diagnostic symptoms of IC/BPS, pain, mood, sexual self-efficacy, and sexual function. Regression explored the relation of urologic symptoms, pain and emotional distress to FSD, and the additional predictive utility of sexual self-efficacy when assessing this relationship.
resultsWhile pelvic and mood symptoms effectively predicted FSD, the addition of sexual self-efficacy to the model produced significant model improvement, such that greater self-efficacy was associated with better sexual functioning, and variance in FSD was no longer predicted by pain or depression.
conclusionResults emphasize the influential role that confidence in ability to manage symptoms plays in FSD, beyond known influences such as mood or symptom severity. Complementing existing treatment with education or intervention including skills-building to increase patient confidence in ability to manage sexual pain may improve sexual function in IC/BPS. A model of intervention appropriate for physician implementation in the clinical setting is discussed, and potential self-management strategies are reviewed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.